# Scynexis (SCYX) — Overview

SCYX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/scyx

## Price

Last close $3.91 on Oct 15, 2026. 52-week range $3.57 – $8.88.

## Company profile

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $19.2M |
| Revenue (quarter) | $235,000.00 |
| Revenue growth (year over year) | -82.77% |
| Gross profit (trailing twelve months) | $19.2M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$10.2M |
| Net income (quarter) | $7.4M |
| Net income growth (year over year) | 207.44% |
| Net margin | -53.26% |
| Return on equity | -18.38% |
| EPS (trailing twelve months) | −$0.91 |
| Book value per share | $6.73 |
| P/E (trailing twelve months) | — |
| Price to book | 0.6 |
| Debt to assets | 10.72% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Scynexis (SCYX) profitable?

No. Scynexis reported a net loss of $10.2M over the trailing twelve months.

### How much revenue does Scynexis (SCYX) make?

Scynexis generated $19.2M in revenue over the trailing twelve months, down 82.77% year over year.

### How do I buy stock in Scynexis (SCYX)?

SCYX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).